Table 5.

Labral degeneration demographics, clinical features and baseline outcome scores

	Operative (n=27)			Non-operative (n=44)
	Mean/n	SD/%	95% CI	Mean/n	SD/%	95% CI	p Value
Age*	59.15	9.07	55.56 to 62.73	65.14	8.48	62.56 to 67.72	0.0064
Gender†							0.7952
Male	18	66.67		28	63.64
Female	9	33.33		16	36.36
Body mass index*	30.07	4.84	28.15 to 31.99	28.94	5.50	27.26 to 30.61	0.3815
Cause of injury†							0.4098
Known	18	66.67		25	56.82
Unknown	9	33.33		19	43.18
Side of injury†							0.5126
Right	17	62.96		31	70.45
Left	10	37.04		13	29.55
Symptom duration†							0.6492
<1 year	15	55.56		22	50
>1 year	12	44.44		22	50
Diabetes†							0.6779
Yes	6	22.22		8	18.18
No	21	77.78		36	81.82
Smoking†							0.7235
Yes	1	3.70		1	2.27
No	26	96.30		43	97.73
Pain VAS*	51.48	25.02	41.58 to 61.38	43.70	27.00	35.29 to 52.11	0.2338
Baseline PCS*	41.38	9.70	36.70 to 46.05	41.36	7.23	38.61 to 44.11	0.9937
Baseline MCS‡	48.43	10.91	43.17 to 53.69	51.52	10.53	47.51 to 55.53	0.4231
Baseline ASES*	49.96	20.61	41.45 to 58.47	58.97	20.89	52.11 to 65.84	0.0973
Baseline WORC*	1158.00	473.10	966.90 to 1349.10	1072.10	446.80	931.10 to 1213.10	0.4562
SAT‡	78.98	26.58	68.01 to 89.95	74.81	29.32	64.58 to 85.04	0.4518
SANE‡	33.83	25.86	23.60 to 44.06	36.07	21.96	29.14 to 43.01	0.5185
SAL*	10.69	3.86	8.63 to 12.74	11.76	5.01	9.48 to 14.04	0.4816

*p values calculated using t-tests.

†p values calculated using χ² tests.

‡p values calculated using Wilcoxon signed-rank tests.

Continuous data presented as mean, SD. Categorical data presented as n (%).

ASES, American Shoulder and Elbow Surgeons; MCS, mental component summary; PCS, physical component summary; SAL, Shoulder Activity Level; SANE, Single Assessment Numeric Evaluation; SAT, Scapular Assistance Test; VAS, Visual Analogue Scale; WORC, Western Ontario Rotator Cuff Index.